Laboratory of Biotechnology, ENEA Casaccia Research Center, Rome, Italy.
Avian Pathology Unit, Pathology and Veterinary Public Health Department, Agronomy and Veterinary Institute Hassan II, Rabat, Morocco.
PLoS One. 2021 Feb 16;16(2):e0247134. doi: 10.1371/journal.pone.0247134. eCollection 2021.
Infectious Bursal Disease Virus (IBDV), the etiological agent of Gumboro disease, causes mortality and immunosuppression in chickens and major losses to poultry industry worldwide. The IBDV major capsid protein VP2 is considered the best candidate for the production of novel subunit vaccines. This structural protein contains the major conformational epitopes responsible for the induction of IBDV neutralizing antibodies in chickens and has been demonstrated able to form supramolecular structures in yeast and insect cells. The aim of this study was to express an engineered version of the VP2 protein (His-pVP2) to verify its ability to self-assemble into virus-like particles in plants. The recombinant VP2 was transiently expressed by agroinfiltration in Nicotiana benthamiana and transmission electron microscopy of sucrose density gradient fractions revealed the presence of a mixed population of differently shaped particles ranging from spherical capsids, with a diameter between ~25 and ~70 nm, to tubular structures, with variable length (from 100 to 400 nm). The recombinant VP2-based particles when used for the intramuscular immunization of specific-pathogen-free chicks resulted able to induce the production of anti-IBDV specific antibodies at titers comparable to those induced by a commercial vaccine. Moreover, all the immunized birds survived to the challenge with a Moroccan very virulent IBDV strain with no major histomorphological alterations of the Bursa of Fabricius, similarly to what obtained with the commercial inactivated vaccine.
传染性法氏囊病病毒(IBDV)是传染性法氏囊病的病原体,可导致鸡死亡和免疫抑制,并给全球家禽业造成重大损失。IBDV 的主要衣壳蛋白 VP2 被认为是生产新型亚单位疫苗的最佳候选物。这种结构蛋白包含主要构象表位,负责诱导鸡体内 IBDV 中和抗体的产生,并且已被证明能够在酵母和昆虫细胞中形成超分子结构。本研究的目的是表达一种经过工程改造的 VP2 蛋白(His-pVP2),以验证其在植物中自我组装成病毒样颗粒的能力。通过农杆菌浸润在本氏烟中瞬时表达重组 VP2,蔗糖密度梯度部分的透射电子显微镜显示存在不同形状的混合颗粒群,从直径约 25 至 70nm 的球形衣壳到长度不同(从 100 至 400nm)的管状结构。基于重组 VP2 的颗粒用于无特定病原体小鸡的肌肉内免疫,可诱导产生与商业疫苗相当的抗 IBDV 特异性抗体。此外,所有免疫的鸡在挑战摩洛哥非常强毒 IBDV 株时均存活,法氏囊的主要组织形态学没有明显改变,与使用商业灭活疫苗获得的结果相似。